Chronic fatigue syndrome and fibromyalgia in Canada: Prevalence and associations with six health status indicators

Health Promotion and Chronic Disease Prevention in Canada

Volumn 35, Issue 1, 2015, Pages 3-11

  Rusu, C ^a   Gee, M E ^a   Lagace C ^a   Parlor, M ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b National ME/FM Action Network   (Canada)

Author keywords

Cross sectional studies; Fibromyalgia; Health status; Health surveys; Myalgic encephalomyelitis

Indexed keywords

ADOLESCENT; ADULT; AGED; CANADA; CHILD; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HEALTH STATUS INDICATOR; HUMAN; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; CANADA; CHILD; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SURVEYS AND QUESTIONNAIRES;

EID: 84925883043     PISSN: None     EISSN: 2368738X     Source Type: Journal    
DOI: 10.24095/hpcdp.35.1.02     Document Type: Article

References (25)

1. Park J, Knudson S. Medically unexplained physical symptoms. Health Rep. 2007;18:43-7.
2. Lavergne MR, Cole DC, Kerr K, Marshall LM. Functional impairment in chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivity. Can Fam Physician. 2010;56:e57-65.
3. Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a communitybased sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med. 2000; 62:655-63.
4. Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990;33:381-7.
5. Westert GP, Satariano WA, Schellevis FG, van der Bos GA. Patterns of comorbidity and the use of health services in the Dutch population. Eur J Public Health 2001;11:365-72.
6. Struijs JN, Baan CA, Schellevis FG, Westert GP, van der Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6:84.
7. Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis. 2004;63:723-9.
8. Bollegala D, Perruccio AV, Badley EM. Combined impact of concomitant arthritis and back problems on health status: results from a nationally representative health survey. Arthritis Care Res (Hoboken). 2011;63:1584-91.
9. El-Gabalawy R, Mackenzie CS, Shooshtari S, et al. Comorbid physical health conditions and anxiety disorders: a populationbased exploration of prevalence and health outcomes among older adults. Gen Hosp Psychiatry. 2011;33:556-4.
10. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851-8.
11. Creed FH, Tomenson B, Chew-Graham C, et al. Multiple somatic symptoms predict impaired health status in functional somatic syndromes. Int J Behav Med. 2013;20:194-205.
12. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care. 1996;34:924-30.
13. Scheeres K, Wensing M, Severens H, Adang E, Bleijenberg G. Determinants of health care use in chronic fatigue syndrome patients: a cross-sectional study. J Psychosom Res. 2008;65:39-46.
14. McNally JD, Matheson DA, Bakowsky VS. The epidemiology of self-reported fibromyalgia in Canada. Chronic Dis Can 2006; 27:9-16.
15. Statistics Canada. Canadian Community Heatlh Survey (CCHS) Annual Component. 2010 and 2009-2010 Microdata File User Guide. 2011 [cited 2013 Jan 31]. Available from: http://www23.statcan.gc.ca/imdb-bmdi/pub/document/3226_D7_T9_V8-eng.htm
16. Deddens JA, Petersen MR, Lei X. Estimation of prevalence ratios when PROC GENMOD does not converge. SAS User Group International (SUGI) Proceedings, Seattle, Washington, March 30-April 2, 2003. Paper #270-28.
17. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17:356.
18. Collin SM, Crawley E, May MT, et al. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217.
19. Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004;21:4.
20. Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Healthresource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171-80.
21. Ursini F, Naty S, Grembiale RD. Fibromyalgia and obesity: the hidden link. Rheumatol Int. 2011;31:1403-8.
22. Goodwin L, White PD, Hotopf M, Standsfield CA, Clark C. Psychopathology and physical activity as predictors of chronic fatigue syndrome in the 1958 British birth cohort: a replication study of the 1946 and 1970 birth cohorts. Ann Epidemiol. 2011;21:343-50.
23. Harvey SB, Wadsworth M, Wessely S, Hotopf M. Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med. 2008;70:488-95.
24. Dobkin PL, De Civita M, Bernatsky S, Kang H, BaronM. Does psychological vulnerability determine health-care utilization in fibromyalgia? Rheumatology (Oxford). 2003;42: 1324-31.
25. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients’ self-reports and on determinants of inaccuracy. J Clin Epidemiol. 1996;49:1407-17.